These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 30175975)
1. Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway. Wang S; He B; Hang W; Wu N; Xia L; Wang X; Zhang Q; Zhou X; Feng Z; Chen Q; Chen J J Alzheimers Dis; 2018; 65(4):1385-1400. PubMed ID: 30175975 [TBL] [Abstract][Full Text] [Related]
2. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes. Yang Y; Ma D; Wang Y; Jiang T; Hu S; Zhang M; Yu X; Gong CX J Alzheimers Dis; 2013; 33(2):329-38. PubMed ID: 22936005 [TBL] [Abstract][Full Text] [Related]
3. Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model. Moghazy HM; Abdelhaliem NG; Mohammed SA; Hassan A; Abdelrahman A Pflugers Arch; 2024 May; 476(5):779-795. PubMed ID: 38536493 [TBL] [Abstract][Full Text] [Related]
4. Berberine ameliorates neuronal AD-like change via activating Pi3k/PGCε pathway. Wu N; Liu W; Wang J; Han Y; Ye Y; Liu X; Yu Y; Chen Q; Bao Y; Liu C Biofactors; 2021 Jul; 47(4):587-599. PubMed ID: 33740285 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic study and neuropharmacological effects of atractylenolide Ⅲ to improve cognitive impairment via PI3K/AKT/GSK3β pathway in intracerebroventricular-streptozotocin rats. Liu G; Xie R; Tan Q; Zheng J; Li W; Wang Q; Liang Y J Ethnopharmacol; 2024 Oct; 333():118420. PubMed ID: 38838925 [TBL] [Abstract][Full Text] [Related]
6. Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/β-catenin/NeuroD1 pathway. Kang X; Wang D; Zhang L; Huang T; Liu S; Feng X; Guo Y; Zhang Z; Wang Z; Ren H; Yuan G Mol Med; 2023 Sep; 29(1):118. PubMed ID: 37667187 [TBL] [Abstract][Full Text] [Related]
7. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells. Chang W; Zhang M; Meng Z; Yu Y; Yao F; Hatch GM; Chen L Eur J Pharmacol; 2015 Dec; 769():55-63. PubMed ID: 26522928 [TBL] [Abstract][Full Text] [Related]
8. Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3-kinase-protein kinase B pathway in diabetic rats. Ni WJ; Zhou H; Ding HH; Tang LQ J Diabetes Investig; 2020 Mar; 11(2):297-306. PubMed ID: 31336024 [TBL] [Abstract][Full Text] [Related]
9. Effects of Berberine on Diabetes and Cognitive Impairment in an Animal Model: The Mechanisms of Action. Zhang JH; Zhang JF; Song J; Bai Y; Deng L; Feng CP; Xu XY; Guo HX; Wang Y; Gao X; Gu Y; Jin C; Zheng JF; Zhen Z; Su H Am J Chin Med; 2021; 49(6):1399-1415. PubMed ID: 34137676 [TBL] [Abstract][Full Text] [Related]
10. Axonal and dendritic changes are associated with diabetic encephalopathy in rats: an important risk factor for Alzheimer's disease. Zhou Y; Luo Y; Dai J J Alzheimers Dis; 2013; 34(4):937-47. PubMed ID: 23302655 [TBL] [Abstract][Full Text] [Related]
11. Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats. Xu W; Liu J; Ma D; Yuan G; Lu Y; Yang Y PLoS One; 2017; 12(2):e0172477. PubMed ID: 28225806 [TBL] [Abstract][Full Text] [Related]
12. Trans-resveratrol Inhibits Tau Phosphorylation in the Brains of Control and Cadmium Chloride-Treated Rats by Activating PP2A and PI3K/Akt Induced-Inhibition of GSK3β. Shati AA; Alfaifi MY Neurochem Res; 2019 Feb; 44(2):357-373. PubMed ID: 30478674 [TBL] [Abstract][Full Text] [Related]
13. Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy. Qiu YY; Tang LQ; Wei W Mol Cell Endocrinol; 2017 Mar; 443():89-105. PubMed ID: 28087385 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons. Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330 [TBL] [Abstract][Full Text] [Related]
15. Ferulic acid attenuates diabetes-induced cognitive impairment in rats via regulation of PTP1B and insulin signaling pathway. Wang H; Sun X; Zhang N; Ji Z; Ma Z; Fu Q; Qu R; Ma S Physiol Behav; 2017 Dec; 182():93-100. PubMed ID: 28988132 [TBL] [Abstract][Full Text] [Related]
16. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes. Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064 [TBL] [Abstract][Full Text] [Related]
17. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus. Ali T; Kim MO J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697 [TBL] [Abstract][Full Text] [Related]
18. Berberine attenuates axonal transport impairment and axonopathy induced by Calyculin A in N2a cells. Liu X; Zhou J; Abid MD; Yan H; Huang H; Wan L; Feng Z; Chen J PLoS One; 2014; 9(4):e93974. PubMed ID: 24713870 [TBL] [Abstract][Full Text] [Related]
19. Seipin deletion in mice enhances phosphorylation and aggregation of tau protein through reduced neuronal PPARγ and insulin resistance. Chang H; Di T; Wang Y; Zeng X; Li G; Wan Q; Yu W; Chen L Neurobiol Dis; 2019 Jul; 127():350-361. PubMed ID: 30910747 [TBL] [Abstract][Full Text] [Related]
20. Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway. Gandhi GR; Jothi G; Antony PJ; Balakrishna K; Paulraj MG; Ignacimuthu S; Stalin A; Al-Dhabi NA Eur J Pharmacol; 2014 Dec; 745():201-16. PubMed ID: 25445038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]